PPARG and Uterine leiomyoma: It has been reported that telmisartan inhibited the estradiol induced proliferation of ELT-3 cells (a uterine leiomyoma cell line) by acting as a PPARγ ligand, and that it inhibited angiotensin II-induced ELT-3 cell proliferation [41].